The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125413481 12541348 1 I 20160621 20160708 20160708 EXP JP-JNJFOC-20160704817 JANSSEN HIBI T, SHUNSEI H, HIROTOSHI K, UKIHIDE T, NORIKO S, KUNIHIKO O, ET AL. INFLIXIMAB THERAPY FOR INTESTINAL, NEUROLOGICAL, AND VASCULAR INVOLVEMENT IN BEHCET DISEASE: EFFICACY,SAFETY, AND PHARMACOKINETICS IN A MULTICENTER,PROSPECTIVE, OPEN-LABEL, SINGLE-ARM PHASE 3 STUDY. CLINICAL TRIAL/EXPERIMENTAL STUDY 2016;95 (24):E3863. 0.00 Y 0.00000 20160708 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125413481 12541348 1 SS INFLIXIMAB, RECOMBINANT INFLIXIMAB 1 Intravenous (not otherwise specified) N 0 10 MG/KG LYOPHILIZED POWDER
125413481 12541348 2 PS INFLIXIMAB, RECOMBINANT INFLIXIMAB 1 Intravenous (not otherwise specified) N 103772 5 MG/KG LYOPHILIZED POWDER

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125413481 12541348 1 Behcet's syndrome
125413481 12541348 2 Behcet's syndrome

Outcome of event

Event ID CASEID OUTC COD
125413481 12541348 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125413481 12541348 Abdominal pain
125413481 12541348 Behcet's syndrome
125413481 12541348 C-reactive protein increased
125413481 12541348 Diarrhoea
125413481 12541348 Melaena
125413481 12541348 Pyrexia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found